Malignant melanoma detected during follow-up: literature review and cases report


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article discusses the possibility of timely diagnosis of malignant melanoma by assessing changes in the dermatoscopic picture of formations during follow-up. An analysis of 23 cases from authors’ own practice, identified mainly in patients at risk, is given. The age of the patients varied from 28 to 70 years, mean age 36.7±10.5 years. Follow-up of pigmented lesions before making a decision on excision was performed out for 3-24 months, on average - 10.5±5.4 months. Changes in the dermatoscopic picture were manifested by an asymmetric increase of the lesion and/or a change of its shape (43.5%), the appearance of a new color (69.6%), the formation of an atypical dermatoscopic structure (65.2%), a change in the pattern of the pigment network (56.5 %), modification of the dermatoscopic model of the structure (21.7%), partial regression of formation (4.3%). The mean diameter of the lesions during the follow-up period increased from 4.2±2.2 to 5.4±2.3 mm, the lesion value of the total dermoscopic score of the ABCD rule increased from 3.4±0.9 to 4.6±1.2 points (P<0.05). Histological examination diagnosed melanoma in situ in 52.2% of cases, in the rest - microinvasive melanoma (Clark level II) with Breslow thickness range from 0.2 to 0.5 mm.

Full Text

Restricted Access

About the authors

Yuri Yu. Sergeev

Society of Dermatoscopy and Optical Diagnostics of the Skin; Central State Medical Academy of Department of Presidential Affairs

Email: tosergeev@gmail.com

D. S Beinusov

Society of Dermatoscopy and Optical Diagnostics of the Skin

V. V Mordovtseva

Society of Dermatoscopy and Optical Diagnostics of the Skin; Moscow State University of Food Production

V. Yu Sergeev

Society of Dermatoscopy and Optical Diagnostics of the Skin; Central State Medical Academy of Department of Presidential Affairs

References

  1. Kittler H., Pehamberger H., Wolff K., Binder M. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J. Am Acad Dermatol. 2000;43(3):467-76. Doi: 10.1067/ mjd.2000.107504.
  2. Menzies S.W., Gutenev A., Avramidis M., et al. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol. 2001;137(12):1583-89. doi: 10.1001/archderm.137.12.1583.
  3. Malvehy J., Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method. Clin Dermatol. 2002;20(3):297- 304. Doi: 10.1016/ s0738-081x(02)00220-1.
  4. Robinson J.K., Nickoloff B.J. Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol. 2004;140(1):49-56. Doi: 10.1001/ archderm.140.1.49.
  5. Bauer J., Blum A., Strohhacker U., Garbe C. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J. Dermatol. 2005;152(1):87- 92. doi: 10.1111/j.1365-2133.2005.06370.x.
  6. Fuller S.R., Bowen G.M., Tanner B., et al. Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatol Surg. 2007;33(10):1198-206. doi: 10.1111/j.1524-4725.2007.33254.x.
  7. Altamura D., Avramidis M., Menzies S.W. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol. 2008;144(4):502-6. doi: 10.1001/archderm.144.4.502.
  8. Flaenssle H.A., Korpas B., Hansen-Hagge C. et al. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol. 2010;146(3):257-64. doi: 10.1001/archdermatol.2009.370.
  9. Argenziano G., Mordente I., Ferrara G., et al. Dermoscopicmonitoring of melanocytic skin lesions: clinical outcome and patient compliance varyaccording to follow-up protocols. Br J. Dermatol. 2008;159(2):331-36. doi: 10.1111/j.1365-2133.2008.08649.x.
  10. Argenziano G., Kittler H., Ferrara G., et al. Slow-growing melanoma: a dermoscopy follow-up study. Br. J. Dermatol. 2010; (2): 267-73. doi: 10.1111/j.1365-2133.2009.09416.x.
  11. Salerni G., Carrera C., Lovatto L., et al. Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma. J. Am Acad Dermatol. 2012;67(5):836-45. Doi: 10.1016/j. jaad.2012.01.028.
  12. Fikrle T., Pizinger K., Szakos H., et al. Digital dermatoscopic follow-up of 1027 melanocytic lesions in 121 patients at risk of malignant melanoma. J. Eur Acad Dermatol Venereol. 2013;27(2):180-86. doi: 10.1111/j.1468- 3083.2011.04438.x.
  13. Ungureanu L., Letca A., Senila S.C., et al. Patterns of change during the dermoscopic follow-up of melanocytic lesions in high risk patients. Clujul Med. 2015;88(1):38-43. Doi: 10.15386/ cjmed-394.
  14. Rinner C., Tschandl P., Sinz C., Kittler H. Long-term evaluation of the efficacy of digital dermatoscopy monitoring at a tertiary referral center. J. Dtsch Dermatol Ges. 2017;15(5):517-22. doi: 10.1111/ddg.13237.
  15. Moscarella E., Tion I., Zalaudek I., et al. Both short-term and long-term dermoscopy monitoring is useful in detecting melanoma in patients with multiple atypical nevi. J. Eur Acad Dermatol Venereol. 2017;31(2):247-51. Doi: 10.1111/ jdv. 13840.
  16. Pampena R., Manfreda V., Kyrgidis A., et al. et al. Digital dermoscopic changes during follow-up of de-novo and nevus-associated melanoma: a cohort study Int J. Dermatol. 2020;59(7):813-21. doi: 10.1111/ijd.14918.
  17. Saura S.P., March-Rodriguez A., Pujol R.M., et al. Two-step digital follow-up of patients at high risk for melanoma: a retrospective analysis of 152 patients. Actas Dermosifiliogr. 2021;112(3):250-56. doi: 10.1016/j.ad.2020.11.004.
  18. Сергеев Ю.Ю., Мордовцева В.В. Опыт диагностики меланомы кожи диаметром менее 6 мм. Клиническая дерматология и венерология. 2018;17(4):97-105. Doi: 10.17116/ klinderma20181704197.
  19. Сергеев Ю.Ю., Сергеев В.Ю., Мордовцева В.В. и др. Меланома кожи в 2019 г: особенности клинической и дерматоскопической картины опухоли на современном этапе. Фарматека. 2020;27(8):28-35. doi: 10.18565/pharmateca.2020.8.28-35.
  20. Geller A.C., Greinert R., Sinclair C., et al. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol. 2010;34(3):355-58. doi: 10.1016/j.canep.2010.03.006.
  21. US Preventive Services Task Force, Bibbins-Domingo K., Grossman D.C., Curry S.J., et al. Screening for skin cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316(4):429-35. Doi: 10.1001/ jama.2016.8465.
  22. Collins M.K., Secrest A.M., Ferris L.K. Screening for melanoma. Melanoma Res. 2014;24(5):428-36. doi: 10.1097/CMR.0000000000000104.
  23. Сергеев Ю.Ю., Сергеев В.Ю., Мордовцева В.В. Динамическое наблюдение за меланоцитарными образованиями при помощи дерматоскопии (обзор литературы). Медицинский алфавит. Серия «Дерматология». 2020;1.6(420):66-71.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies